TScan Therapeutics (TCRX) Non-Current Deferred Revenue (2020 - 2025)
TScan Therapeutics' Non-Current Deferred Revenue came in at $501,000 for Q1 2025, down 89.5% from $4.76 million a year earlier and down 59.8% from the prior quarter.
TScan Therapeutics (TCRX) Non-Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, TScan Therapeutics' Non-Current Deferred Revenue was $1.25 million, down 77.8% from FY2023.
- Non-Current Deferred Revenue carries a four-year compound annual growth rate of -38.7% (FY2020 to FY2024).
- Going back by year, Non-Current Deferred Revenue was $5.62 million in FY2023, $1.5 million in FY2021 (-83.0%) and $8.82 million in FY2020.
- The Q1 2025 figure represents the lowest quarterly Non-Current Deferred Revenue in data going back to Q4 2020.
- Year-over-year, Non-Current Deferred Revenue has declined for four consecutive quarters, with an average decline of 67.0% over the last four quarters.
- Business Quant data shows TCRX's Non-Current Deferred Revenue at $1.25 million (Q4 2024), $3.68 million (Q3 2024) and $3.96 million (Q2 2024) in the three quarters before Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 501,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 7.64 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 2.84 Mn |
| Jun 30, 2021 | 4.56 Mn |
| Dec 31, 2020 | 8.82 Mn |
TScan Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();